Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

Biologics targeting interleukin-12, -23, and -17 were associated with a lower rate of serious infections among older adults ...

Posters presented at the 2025 American Academy of Dermatology Annual Meeting found bimekizumab to have benefits beyond safety ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...

Patients with osteoarthritis, but not immune-related arthritis, demonstrate increased odds for developing overactive bladder ...

More than half of patients with fingernail psoriasis achieved complete fingernail clearance after 68 weeks of guselkumab treatment.

Arthritis is one of the most common chronic conditions affecting millions of people worldwide. Yet, many fail to recognize ...

Growing up, I watched my mom apply fun lipsticks, powder her face in small compact mirrors, and make sure her lashes were ...

Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life ...

Celltrion, Inc., a leading global biopharmaceutical company, announced today that its infliximab biosimilar will be marketed in Canada under the new b ...